Emodin at a concentration of 20 μg/mL in MCF-7/Adr cells significantly decreased excision repair cross complementation group 1 (ERCC1) expression, which can lead to multi-drug resistance to chemotherapy in cancer treatment [92]. The gene discussed is ERCC1; the disease is cancer.